Reorder RefillGet Started

Medical Weight Loss in Los Angeles County

Physician-supervised GLP-1 programs for the 12 cities of Los Angeles County. Served via California telemedicine. Doctor review $119, semaglutide from $166/month · just $5.50/day, bilingual support available.

A serene Southern California coastal setting
Los Angeles County. We serve all of Los Angeles County through California telemedicine, from Long Beach to Santa Clarita, from Santa Monica to Pomona, with medication fulfillment considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment.

Cities We Serve in Los Angeles County

Burbank Downey Glendale Inglewood Lakewood Long Beach Los Angeles Pasadena Pomona Santa Clarita Santa Monica Torrance

How It Works

Complete the intake form online, Dr. Sharma reviews your history by secure video, after intake review, and if you are a candidate, medication fulfillment is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment. Follow-ups are by video too.

More Resources

All our California service areas How our 90-day program works Frequently asked questions
Explore our GLP-1 programs: Semaglutide from $166/mo · Tirzepatide from $233/mo · just $7.70/day · Weight Loss Injections · Savings Calculator

Los Angeles County, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Los Angeles County

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.